Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9973 to 9984 of 23887 entries
Sorted by: Best Match Show Resources per page
Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines.

Journal of stroke

Kim JS.
PMID: 34102752
J Stroke. 2021 May;23(2):149-161. doi: 10.5853/jos.2021.01249. Epub 2021 May 31.

Hyperlipidemia is an important risk factor for ischemic stroke; the Stroke Prevention by Aggressive Reduction in Cholesterol Level and Treat Stroke to Target studies have shown that statins are beneficial for patients with stroke and that a low target...

Cite
Kim JS. Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines. J Stroke. 2021;23(2):149-161doi: 10.5853/jos.2021.01249.
Kim, J. S. (2021). Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines. Journal of stroke, 23(2), 149-161. https://doi.org/10.5853/jos.2021.01249
Kim, Jong S. "Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines." Journal of stroke vol. 23,2 (2021): 149-161. doi: https://doi.org/10.5853/jos.2021.01249
Kim JS. Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines. J Stroke. 2021 May;23(2):149-161. doi: 10.5853/jos.2021.01249. Epub 2021 May 31. PMID: 34102752; PMCID: PMC8189863.
Copy Download .nbib Format: NLM
Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus.

Disease markers

Huang J, Gu JX, Bao HZ, Li SS, Yao XQ, Yang M, Li Y, Zhang AM, Yin Y, Zhang N, Jia M, Su M.
PMID: 34046097
Dis Markers. 2021 May 10;2021:5597028. doi: 10.1155/2021/5597028. eCollection 2021.

BACKGROUND: Coronary heart disease (CHD) is a common and severe complication in type 2 diabetes mellitus (T2DM) patients. Increased amount of circulatory small dense low-density lipoprotein cholesterol (sdLDL-C) particles is known to be a sign of dyslipidemia and can...

Cite
Huang J, Gu JX, Bao HZ, et al. Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus. Dis Markers. 2021;2021:5597028doi: 10.1155/2021/5597028.
Huang, J., Gu, J. X., Bao, H. Z., Li, S. S., Yao, X. Q., Yang, M., Li, Y., Zhang, A. M., Yin, Y., Zhang, N., Jia, M., & Su, M. (2021). Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus. Disease markers, 20215597028. https://doi.org/10.1155/2021/5597028
Huang, Juan, et al. "Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus." Disease markers vol. 2021 (2021): 5597028. doi: https://doi.org/10.1155/2021/5597028
Huang J, Gu JX, Bao HZ, Li SS, Yao XQ, Yang M, Li Y, Zhang AM, Yin Y, Zhang N, Jia M, Su M. Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus. Dis Markers. 2021 May 10;2021:5597028. doi: 10.1155/2021/5597028. eCollection 2021. PMID: 34046097; PMCID: PMC8128552.
Copy Download .nbib Format: NLM
Tuning the Diameter, Stability, and Membrane Affinity of Peptide Pores by DNA-Programmed Self-Assembly.

ACS nano

Fennouri A, List J, Ducrey J, Dupasquier J, Sukyte V, Mayer SF, Vargas RD, Pascual Fernandez L, Bertani F, Rodriguez Gonzalo S, Yang J, Mayer M.
PMID: 34128638
ACS Nano. 2021 Jun 15; doi: 10.1021/acsnano.0c10311. Epub 2021 Jun 15.

Protein pores recently enabled a breakthrough in bioanalytics by making it possible to sequence individual DNA and RNA strands during their translocation through the lumen of the pore. Despite this success and the overall promise of nanopore-based single-molecule analytics,...

Cite
Fennouri A, List J, Ducrey J, et al. Tuning the Diameter, Stability, and Membrane Affinity of Peptide Pores by DNA-Programmed Self-Assembly. ACS Nano. 2021;doi: 10.1021/acsnano.0c10311.
Fennouri, A., List, J., Ducrey, J., Dupasquier, J., Sukyte, V., Mayer, S. F., Vargas, R. D., Pascual Fernandez, L., Bertani, F., Rodriguez Gonzalo, S., Yang, J., & Mayer, M. (2021). Tuning the Diameter, Stability, and Membrane Affinity of Peptide Pores by DNA-Programmed Self-Assembly. ACS nano, . https://doi.org/10.1021/acsnano.0c10311
Fennouri, Aziz, et al. "Tuning the Diameter, Stability, and Membrane Affinity of Peptide Pores by DNA-Programmed Self-Assembly." ACS nano vol. (2021). doi: https://doi.org/10.1021/acsnano.0c10311
Fennouri A, List J, Ducrey J, Dupasquier J, Sukyte V, Mayer SF, Vargas RD, Pascual Fernandez L, Bertani F, Rodriguez Gonzalo S, Yang J, Mayer M. Tuning the Diameter, Stability, and Membrane Affinity of Peptide Pores by DNA-Programmed Self-Assembly. ACS Nano. 2021 Jun 15; doi: 10.1021/acsnano.0c10311. Epub 2021 Jun 15. PMID: 34128638.
Copy Download .nbib Format: NLM
Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells.

World journal of clinical cases

Fu BB, Zhao JN, Wu SD, Fan Y.
PMID: 34046450
World J Clin Cases. 2021 May 26;9(15):3498-3505. doi: 10.12998/wjcc.v9.i15.3498.

Cholesterol gallstone (CG) is a common, frequent biliary system disease in China, with a complex and multifactorial etiology. Declined gallbladder motility reportedly contributes to CG pathogenesis. Furthermore, interstitial Cajal-like cells (ICLCs) are reportedly present in human and guinea pig...

Cite
Fu BB, Zhao JN, Wu SD, et al. Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells. World J Clin Cases. 2021;9(15):3498-3505doi: 10.12998/wjcc.v9.i15.3498.
Fu, B. B., Zhao, J. N., Wu, S. D., & Fan, Y. (2021). Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells. World journal of clinical cases, 9(15), 3498-3505. https://doi.org/10.12998/wjcc.v9.i15.3498
Fu, Bei-Bei, et al. "Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells." World journal of clinical cases vol. 9,15 (2021): 3498-3505. doi: https://doi.org/10.12998/wjcc.v9.i15.3498
Fu BB, Zhao JN, Wu SD, Fan Y. Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells. World J Clin Cases. 2021 May 26;9(15):3498-3505. doi: 10.12998/wjcc.v9.i15.3498. PMID: 34046450; PMCID: PMC8130069.
Copy Download .nbib Format: NLM
The Risk of Chronic Diseases in Individuals Responding to a Measure for the Initial Screening of Depression and Reported Feelings of Being Down, Depressed, or Hopeless.

Cureus

Khatib M, Badillo N, Kahar P, Khanna D.
PMID: 34646682
Cureus. 2021 Sep 01;13(9):e17634. doi: 10.7759/cureus.17634. eCollection 2021 Sep.

Introduction Feeling down, depressed, or hopeless may provide a comprehensive measure for physicians to utilize, allowing a possible way to assess risk for chronic diseases. Methods A face-to-face, in-home, validated survey was conducted on participants aged 16 and older....

Cite
Khatib M, Badillo N, Kahar P, et al. The Risk of Chronic Diseases in Individuals Responding to a Measure for the Initial Screening of Depression and Reported Feelings of Being Down, Depressed, or Hopeless. Cureus. 2021;13(9):e17634doi: 10.7759/cureus.17634.
Khatib, M., Badillo, N., Kahar, P., & Khanna, D. (2021). The Risk of Chronic Diseases in Individuals Responding to a Measure for the Initial Screening of Depression and Reported Feelings of Being Down, Depressed, or Hopeless. Cureus, 13(9), e17634. https://doi.org/10.7759/cureus.17634
Khatib, Mohammed, et al. "The Risk of Chronic Diseases in Individuals Responding to a Measure for the Initial Screening of Depression and Reported Feelings of Being Down, Depressed, or Hopeless." Cureus vol. 13,9 (2021): e17634. doi: https://doi.org/10.7759/cureus.17634
Khatib M, Badillo N, Kahar P, Khanna D. The Risk of Chronic Diseases in Individuals Responding to a Measure for the Initial Screening of Depression and Reported Feelings of Being Down, Depressed, or Hopeless. Cureus. 2021 Sep 01;13(9):e17634. doi: 10.7759/cureus.17634. eCollection 2021 Sep. PMID: 34646682; PMCID: PMC8486358.
Copy Download .nbib Format: NLM
The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases.

Clinica chimica acta; international journal of clinical chemistry

Vural H, Armutcu F, Akyol O, Weiskirchen R.
PMID: 34678296
Clin Chim Acta. 2021 Dec;523:374-379. doi: 10.1016/j.cca.2021.10.018. Epub 2021 Oct 19.

Non-alcoholic fatty liver disease (NAFLD) is an umbrella term for a range of conditions caused by a build-up of fat in the liver. It is usually seen in people who are overweight or obese. Increasingly common around the world,...

Cite
Vural H, Armutcu F, Akyol O, et al. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clin Chim Acta. 2021;523:374-379doi: 10.1016/j.cca.2021.10.018.
Vural, H., Armutcu, F., Akyol, O., & Weiskirchen, R. (2021). The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica chimica acta; international journal of clinical chemistry, 523374-379. https://doi.org/10.1016/j.cca.2021.10.018
Vural, Hüseyin, et al. "The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases." Clinica chimica acta; international journal of clinical chemistry vol. 523 (2021): 374-379. doi: https://doi.org/10.1016/j.cca.2021.10.018
Vural H, Armutcu F, Akyol O, Weiskirchen R. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clin Chim Acta. 2021 Dec;523:374-379. doi: 10.1016/j.cca.2021.10.018. Epub 2021 Oct 19. PMID: 34678296.
Copy Download .nbib Format: NLM
1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.

European review for medical and pharmacological sciences

Bukhari IA, Mohamed OY, Mahmood A, Alfadda AA, Almotrefi AA.
PMID: 34109592
Eur Rev Med Pharmacol Sci. 2021 Jan;25(10):3835-3847. doi: 10.26355/eurrev_202101_25951.

OBJECTIVE: Obesity was induced in rats by feeding on a high fat diet (HFD), 60% w/w cholesterol, 20% w/w carbohydrates, and 20% w/w proteins for two months.MATERIALS AND METHODS: Animals were fed on a HFD and treated concurrently with...

Cite
Bukhari IA, Mohamed OY, Mahmood A, et al. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats. Eur Rev Med Pharmacol Sci. 2021;25(10):3835-3847doi: 10.26355/eurrev_202101_25951.
Bukhari, I. A., Mohamed, O. Y., Mahmood, A., Alfadda, A. A., & Almotrefi, A. A. (2021). 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats. European review for medical and pharmacological sciences, 25(10), 3835-3847. https://doi.org/10.26355/eurrev_202101_25951
Bukhari, I A, et al. "1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats." European review for medical and pharmacological sciences vol. 25,10 (2021): 3835-3847. doi: https://doi.org/10.26355/eurrev_202101_25951
Bukhari IA, Mohamed OY, Mahmood A, Alfadda AA, Almotrefi AA. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats. Eur Rev Med Pharmacol Sci. 2021 Jan;25(10):3835-3847. doi: 10.26355/eurrev_202101_25951. PMID: 34109592.
Copy Download .nbib Format: NLM
Effect on physiological and production parameters upon supplementation of fermented yeast culture to Nicobari chickens during and post summer.

Journal of animal physiology and animal nutrition

Nidamanuri AL, Prince LLL, Mahapatra RK, Murugesan S.
PMID: 34110055
J Anim Physiol Anim Nutr (Berl). 2021 Jun 10; doi: 10.1111/jpn.13579. Epub 2021 Jun 10.

Nicobari is an indigenous bird reared for meat and eggs. This study evaluated the effect of heat stress on plasma levels of leptin, growth hormone and their receptors, liver AMP kinase, plasma cholesterol and lipid peroxide (MDA). The laying...

Cite
Nidamanuri AL, Prince LLL, Mahapatra RK, et al. Effect on physiological and production parameters upon supplementation of fermented yeast culture to Nicobari chickens during and post summer. J Anim Physiol Anim Nutr (Berl). 2021;doi: 10.1111/jpn.13579.
Nidamanuri, A. L., Prince, L. L. L., Mahapatra, R. K., & Murugesan, S. (2021). Effect on physiological and production parameters upon supplementation of fermented yeast culture to Nicobari chickens during and post summer. Journal of animal physiology and animal nutrition, . https://doi.org/10.1111/jpn.13579
Nidamanuri, Anand Laxmi, et al. "Effect on physiological and production parameters upon supplementation of fermented yeast culture to Nicobari chickens during and post summer." Journal of animal physiology and animal nutrition vol. (2021). doi: https://doi.org/10.1111/jpn.13579
Nidamanuri AL, Prince LLL, Mahapatra RK, Murugesan S. Effect on physiological and production parameters upon supplementation of fermented yeast culture to Nicobari chickens during and post summer. J Anim Physiol Anim Nutr (Berl). 2021 Jun 10; doi: 10.1111/jpn.13579. Epub 2021 Jun 10. PMID: 34110055.
Copy Download .nbib Format: NLM
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association.

Hypertension (Dallas, Tex. : 1979)

Barone Gibbs B, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, Spartano NL, Lobelo F.
PMID: 34074137
Hypertension. 2021 Aug;78(2):e26-e37. doi: 10.1161/HYP.0000000000000196. Epub 2021 Jun 02.

Current guidelines published by the American Heart Association and the American College of Cardiology broadly recommend lifestyle approaches to prevent and treat elevated blood pressure and cholesterol. For patients with mildly or moderately elevated blood pressure and blood cholesterol,...

Cite
Barone Gibbs B, Hivert MF, Jerome GJ, et al. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension. 2021;78(2):e26-e37doi: 10.1161/HYP.0000000000000196.
Barone Gibbs, B., Hivert, M. F., Jerome, G. J., Kraus, W. E., Rosenkranz, S. K., Schorr, E. N., Spartano, N. L., Lobelo, F. (2021). Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension (Dallas, Tex. : 1979), 78(2), e26-e37. https://doi.org/10.1161/HYP.0000000000000196
Barone Gibbs, Bethany, et al. "Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association." Hypertension (Dallas, Tex. : 1979) vol. 78,2 (2021): e26-e37. doi: https://doi.org/10.1161/HYP.0000000000000196
Barone Gibbs B, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, Spartano NL, Lobelo F. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension. 2021 Aug;78(2):e26-e37. doi: 10.1161/HYP.0000000000000196. Epub 2021 Jun 02. PMID: 34074137.
Copy Download .nbib Format: NLM
The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies.

Pharmacological research

Marinho AT, Batuca JR, Miranda JP, Caixas U, Dias CG, Branco T, Soto K, Pinheiro P, Bourbon M, Marques MM, Antunes AM, Monteiro EC, Pereira SA.
PMID: 33515705
Pharmacol Res. 2021 Mar;165:105446. doi: 10.1016/j.phrs.2021.105446. Epub 2021 Jan 27.

The antiretroviral nevirapine (NVP) is associated to a reduction of atherosclerotic lesions and increases in high-density lipoprotein (HDL)-cholesterol. Despite being a hepatotoxic drug, which forbids its re-purposing to other therapeutic areas, not all NVP metabolites have the same potential...

Cite
Marinho AT, Batuca JR, Miranda JP, et al. The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies. Pharmacol Res. 2021;165:105446doi: 10.1016/j.phrs.2021.105446.
Marinho, A. T., Batuca, J. R., Miranda, J. P., Caixas, U., Dias, C. G., Branco, T., Soto, K., Pinheiro, P., Bourbon, M., Marques, M. M., Antunes, A. M., Monteiro, E. C., & Pereira, S. A. (2021). The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies. Pharmacological research, 165105446. https://doi.org/10.1016/j.phrs.2021.105446
Marinho, Aline T, et al. "The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies." Pharmacological research vol. 165 (2021): 105446. doi: https://doi.org/10.1016/j.phrs.2021.105446
Marinho AT, Batuca JR, Miranda JP, Caixas U, Dias CG, Branco T, Soto K, Pinheiro P, Bourbon M, Marques MM, Antunes AM, Monteiro EC, Pereira SA. The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies. Pharmacol Res. 2021 Mar;165:105446. doi: 10.1016/j.phrs.2021.105446. Epub 2021 Jan 27. PMID: 33515705.
Copy Download .nbib Format: NLM
A Systematic Review of the Cardiometabolic Benefits of Plant Products Containing Mixed Phenolics and Polyphenols in Postmenopausal Women: Insufficient Evidence for Recommendations to This Specific Population.

Nutrients

Sánchez-Martínez L, Periago MJ, García-Alonso J, García-Conesa MT, González-Barrio R.
PMID: 34959828
Nutrients. 2021 Nov 27;13(12). doi: 10.3390/nu13124276.

Menopause is characterized by endocrine and physiological changes and is often accompanied by increased body weight and cholesterol, glucose intolerance, and/or hypertension. These alterations are associated with increased risk for cardiovascular diseases (CVDs) and Type II diabetes mellitus (T2DM)...

Cite
Sánchez-Martínez L, Periago MJ, García-Alonso J, et al. A Systematic Review of the Cardiometabolic Benefits of Plant Products Containing Mixed Phenolics and Polyphenols in Postmenopausal Women: Insufficient Evidence for Recommendations to This Specific Population. Nutrients. 2021;13(12)doi: 10.3390/nu13124276.
Sánchez-Martínez, L., Periago, M. J., García-Alonso, J., García-Conesa, M. T., & González-Barrio, R. (2021). A Systematic Review of the Cardiometabolic Benefits of Plant Products Containing Mixed Phenolics and Polyphenols in Postmenopausal Women: Insufficient Evidence for Recommendations to This Specific Population. Nutrients, 13(12), . https://doi.org/10.3390/nu13124276
Sánchez-Martínez, Lorena, et al. "A Systematic Review of the Cardiometabolic Benefits of Plant Products Containing Mixed Phenolics and Polyphenols in Postmenopausal Women: Insufficient Evidence for Recommendations to This Specific Population." Nutrients vol. 13,12 (2021). doi: https://doi.org/10.3390/nu13124276
Sánchez-Martínez L, Periago MJ, García-Alonso J, García-Conesa MT, González-Barrio R. A Systematic Review of the Cardiometabolic Benefits of Plant Products Containing Mixed Phenolics and Polyphenols in Postmenopausal Women: Insufficient Evidence for Recommendations to This Specific Population. Nutrients. 2021 Nov 27;13(12). doi: 10.3390/nu13124276. PMID: 34959828; PMCID: PMC8707028.
Copy Download .nbib Format: NLM
Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos.

PloS one

Urashima K, Miramontes A, Garcia LA, Coletta DK.
PMID: 34714849
PLoS One. 2021 Oct 29;16(10):e0259449. doi: 10.1371/journal.pone.0259449. eCollection 2021.

Metabolic syndrome (MetS) is highly prevalent worldwide. In the United States, estimates show that more than 30% of the adult population has MetS. MetS consists of multiple phenotypes, including obesity, dyslipidemia, and impaired glucose tolerance. Therefore, identifying the molecular...

Cite
Urashima K, Miramontes A, Garcia LA, et al. Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos. PLoS One. 2021;16(10):e0259449doi: 10.1371/journal.pone.0259449.
Urashima, K., Miramontes, A., Garcia, L. A., & Coletta, D. K. (2021). Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos. PloS one, 16(10), e0259449. https://doi.org/10.1371/journal.pone.0259449
Urashima, Keane, et al. "Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos." PloS one vol. 16,10 (2021): e0259449. doi: https://doi.org/10.1371/journal.pone.0259449
Urashima K, Miramontes A, Garcia LA, Coletta DK. Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos. PLoS One. 2021 Oct 29;16(10):e0259449. doi: 10.1371/journal.pone.0259449. eCollection 2021. PMID: 34714849; PMCID: PMC8555810.
Copy Download .nbib Format: NLM
Showing 9973 to 9984 of 23887 entries